All Research on Biotech

Insight

Case Studies
Case Studies

Alexion Pharmaceuticals, Inc.: Focus on ultra-rare diseases as a revenue and profit driver

In 2007, Alexion gained marketing approval for Soliris, which has since become the world’s single most expensive orphan drug. This case study analyzes Alexion's success with Soliris, potential challenges, and how it is combatting these going forward.

Published By MarketLine
$495
Buy
Report
Report

The Orphan Drug Market Outlook to 2017

This report provides an analysis of the orphan drug market. It comprises brands that have gained US FDA orphan drug approval, as well as Phase III pipeline candidates that have gained an orphan drug designation from the FDA.

Published By Datamonitor
$2800
Buy
Report
Report

Hemophilia Pipeline Overview – Once-a-week prophylaxis may soon become a reality

Datamonitor provides an overview of and profiles key hemophilia A and B pipeline products launching in the near future in the US and five major EU markets (France, Germany, Italy, Spain, and the UK).

Published By Datamonitor
$2800
Buy

View all Insight >>

Profiles

Company Profile
Company Profile

UCB S.A.

UCB (or 'the company') is a global biopharmaceutical company focused on the discovery and development for people living with severe diseases of the immune system or of the central nervous system (CNS). It has operations in about 40 countries across Europe, North America and Asia Pacific. It is headquartered in Brussels, Belgium, and employed 8,684 people as of December 31, 2014.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

Genzyme Corporation

Genzyme (or 'the company'), a Sanofi company, is one of the world's leading biotechnology companies. The company offers medicines for rare inherited disorders, kidney diseases, orthopaedics, cancer, and transplant and immune disease. Genzyme primarily operates in the Americas and Europe. It is headquartered in Cambridge, Massachusetts.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

Gilead Sciences, Inc.

Gilead Sciences (Gilead or 'the company') is a research-based biopharmaceutical company engaged in developing and marketing therapies for HIV/AIDS, liver diseases, oncology, inflammation and serious cardiovascular and respiratory conditions. The company operates in the US, Europe and other countries. It is headquartered in Foster City, California, and employed about 7,000 people as of January 31, 2015.

Published By MarketLine
$175
Buy

View all Profiles >>

No help is available.